Lipid News

An ever-growing role for a tiny lipid

Nicholas Vitale
By Nicholas Vitale
June 1, 2019

Critical signaling functions have been attributed to phosphatidic acid, or PA, the smallest building block in phospholipid biosynthesis. With a small head group and a net negative charge ranging from -1 to -2 depending on pH, PA can modulate local membrane geometry and recruit a large set of specific proteins to confined membrane subdomains; a recent review by Emeline Tanguy and colleagues summarizes both of these essential actions for PA’s signaling function. PA is versatile and challenging because it can be produced and metabolized by a large set of enzymes.

Although PA is present at low levels in most cell types, it appears to be critical for neuronal and glial cell function. Several neurological diseases maybe attributed, at least in part, to altered PA synthesis and/or catabolism. For example, Ricardos Tabet and colleagues proposed in 2016 that an alteration of the PA/diacylglycerol balance could be a main cause of fragile X syndrome, a genetic cause of intellectual disability. They showed that diacylglycerol kinase-kappa, or DGK-kappa, mRNA was the main target of fragile X mental retardation protein and that reduced DGK-kappa expression impaired PA synthesis in neurons from mice bred not to express FMR1, a protein that male fragile X patients lack. Silencing DGK-kappa in pyramidal neurons from the CA1 region of the hippocampus largely reproduced fragile X symptoms. This PA/DAG imbalance is thus likely to affect DAG and PA downstream signaling required for both maturation of dendritic spines and establishment of correct synaptic plasticity.
 

Phosphatidic acid figure Phosphatidic acid is defined by its shape and charge. This conical lipid generates negative membrane curvature and is negatively charged, thereby recruiting positively charged proteins. Nicolas Vitale

Maria Zeniou–Meyer and colleagues in 2008 proposed that the loss of expression of the kinase RSK2, which leads to Coffin–Lowry syndrome (a rare syndromic form of mental retardation), reduced PA synthesis and distorted neurosecretion. Increased PA synthesis has been reported in gliobastoma, the most frequent and aggressive brain cancer. A link between brain PA levels and Alzheimer’s disease also is starting to emerge, but the exact effects of PA imbalance in neurodegeneration and cognitive deficits has not been identified. Finally, reduced PA synthesis may contribute to fetal alcohol spectrum disorders, as ethanol leads to phospholipase D-mediated phosphatidylethanol production at the expense of PA.

Many cellular pleiotropic functions of PA rely on its ability to regulate actin cytoskeleton dynamics and to modulate membrane-involved functions. The former occurs mainly through PA’s ability to modulate the activity of small GTPases, including Rho and Arf members. The latter probably results both from the original cone shape structure of PA favoring negative membrane curvature and from PA’s net negative charge allowing local recruitment of specific proteins. One remaining challenge is to define precisely sites of PA synthesis within the brain and at the subcellular level in neurons. Recent improvements in lipidomics allow for sensitive quantification of dozens of PA species made with different fatty acids. According to a study by Nawal Kassas and colleagues, the development of novel genetically encoded PA sensors also will be crucial in localizing and potentially quantifying changes in PA and perhaps different PA species.

Despite PA’s low abundance, its relative simplicity, and the complexity of its metabolic and signaling pathways, improved understanding of its multiple functions in brain development and function is now within reach.

Nicholas Vitale
Nicholas Vitale

Nicholas Vitale is a group leader at the Institut des Neurosciences Cellulaires et Intégratives at the Centre National de la Recherche Scientifique & Université de Strasbourg and a member of the Journal of Biological Chemistry’s editorial board. Follow him on Twitter.

Related articles

Lipid regulation of mitochondria
Yoshihiro Adachi, Miho Iijima & Hiromi Sesaki
Unexpected roles of lipid kinases
Kaoru Goto & Toshiaki Tanaka
Lipid control of nutrient signaling
Alexander Wallroth & Volker Haucke
From the journals: JLR
Clementine Adeyemi
A surprising modification lowers the lipid binding affinity of a membrane trafficking protein
Jefferson Knight, Colin T. Shearn & Cisloynny Beauchamp–Pérez

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

A molecular determinant of membrane protein targeting
Lipid News

A molecular determinant of membrane protein targeting

Sept. 22, 2021

A study found that a nuclear envelope-localized protein depends on cardiolipin for translocation to its target membrane.

Nautilus founder unspirals a new approach to proteomics
Feature

Nautilus founder unspirals a new approach to proteomics

Sept. 21, 2021

Parag Mallick may be trying to launch a competing proteomics technique, but you won’t catch him badmouthing mass spectrometers.

From pigeon guano to the brain
Health Observance

From pigeon guano to the brain

Sept. 20, 2021

Exploring the journey of the deadly fungal pathogen Cryptococcus neoformans (and its less widespread but still quite serious cousin C. gattii).

Deadly fungal infections
Science Communication

Deadly fungal infections

Sept. 19, 2021

For hospitalized COVID-19 patients, antimicrobial-resistant infections may be a particularly devastating risk of hospitalization.

Scientists must speak out against 'immune-boosting' supplements
Science Communication

Scientists must speak out against 'immune-boosting' supplements

Sept. 18, 2021

Supplements that claim to supercharge your T-cells, make your antibodies hum and otherwise make you invincible are all bunk, and scientists should speak out more about this misinformation.

Finding the right research path
Interview

Finding the right research path

Sept. 16, 2021

Karen Bornfeldt, an associate editor for the Journal of Lipid Research, investigates how diabetes increases cardiovascular disease risk.